[Federal Register Volume 64, Number 125 (Wednesday, June 30, 1999)]
[Notices]
[Page 35172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16589]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


The National Vaccine Program Office (NVPO), of the Centers for 
Disease Control and Prevention (CDC), Announces the Following Meeting

    Name: International Symposium on Combination Vaccines.
    Times and Dates: 8:30 a.m.-6 p.m., February 2, 2000. 9 a.m.-6 
p.m., February 3, 2000. 8:30 a.m.-5 p.m., February 4, 2000.
    Place: Natcher Auditorium, NIH Campus, Bethesda, Maryland.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 500 people.
    Purpose: The purpose of the meeting is to fully explore 
laboratory, clinical, and epidemiologic data integral to developing 
and licensing new safe and effective combination vaccines.
    Matters To Be Discussed: Agenda items will include presentations 
and discussion regarding: immunogenicity; immune interference; 
correlates of protection; pre- and post-licensure safety evaluation; 
combination vaccines vs. simultaneous administration; manufacturing, 
product testing, and preclinical (animal) evaluation; and overcoming 
challenges to use of combination vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Alicia S. Postema, Health 
Policy Fellow, NVPO, CDC, 1600 Clifton Road, NE, M/S A-11, Atlanta, 
Georgia 30333, telephone 404/639-4450.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 23, 1999.
Carolyn Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 99-16589 Filed 6-29-99; 8:45 am]
BILLING CODE 4163-18-P